In the HOME trial, Kooy et al. enrolled 390 insulin dependent participants with an average diabetes duration of 13 years who were randomized to receive metformin or placebo for an average follow-up of 4.3 years [18]. The gene discussed is INS; the disease is diabetes mellitus.